May 2023

Unison Pharmaceuticals Private Limited was established in 1981 with a vision of providing quality & most affordable medicines across the nation. With more than 3 decades of medical service to the society, Unison is today one of the fastest growing company in Gujarat State. The base of operation being a single state, the company has very strong footing in the market. The company strictly believes in ethics and moral values throughout the operations of the business.

The U.S. Food and Drug Administration approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex, for patients 18 years of age and older.

Johnson & Johnson has settled its lawsuit over Amgen's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.

Amgen said in a statement on Tuesday that the settlement terms are confidential, but it will allow the company to sell its biosimilar of Stelara "no later than January 1st, 2025."

SSUHS, a state university of the government of Assam, announced that a common entrance examination will be held for admission into D.Pharm and B.Pharm courses in the institutes of Assam affiliated to SSUHS for session 2023 including institutes run under private sector.

The history of Constitution of India reveals that the concept of conducting competitive examination for appointment to certain posts came into consideration way back in the year 1853 and a committee for giving shape to that was constituted under the chairmanship of Lord Macaulay in the year 1854. Later on the Federal Public Service Commission and the State Public Service Commissions were constituted under the Government of India Act, 1935.

The AIIMS, New Delhi model will be adopted and adapted. Unlike the Postgraduate Institutes which lack the basic departments like Anatomy, Physiology, Pharmacology, General Medicine, Surgery, Obstetrics & Gynaecology etc, the new AIIMS will have these departments as well as the superspecialty departments like neurosurgery, cardiac surgery, urology, endocrinology etc.

Post : Junior Research Fellow (1 Position)

NIAB, an autonomous institute under the aegis of the Department of Biotechnology, Ministry of Science & Technology, Government of India, is aimed to harness novel and emerging biotechnologies and create knowledge in the cutting edge areas for improving animal health and productivity. The Institute’s research focus is on animal genetics and genomics, transgenesis, stem cell & its applications, reproductive biotechnology, infectious diseases, nanotechnology, bioinformatics and Nutrigenomics.

Centre for Cellular and Molecular Platforms (C-CAMP), is a Dept. of Biotechnology (Govt. of India) initiative and a not for profit organization based in Bangalore. We act as an enabler of Bioscience Research, Innovation and Entrepreneurship by providing Research, Development, Training and Services in State Of The Art Technology Platforms.

The AIIMS, New Delhi model will be adopted and adapted. Unlike the Postgraduate Institutes which lack the basic departments like Anatomy, Physiology, Pharmacology, General Medicine, Surgery, Obstetrics & Gynaecology etc, the new AIIMS will have these departments as well as the superspecialty departments like neurosurgery, cardiac surgery, urology, endocrinology etc.

Post : Junior Research Fellow (1 Position)